Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Hillary win may pose pricing challenges for pharma industry: Report

      Hillary win may pose pricing challenges for pharma industry: Report

      supriya kashyap kashyap8 Nov 2016 12:07 PM IST
      Mumbai : A Democrat sweep in US polls may pose even greater pricing challenges for the pharma industry and pave the way for tighter pricing...
      Three US senators ask Mylan for EpiPen military reimbursements

      Three US senators ask Mylan for EpiPen military reimbursements

      supriya kashyap kashyap8 Nov 2016 12:02 PM IST
      Three members of the U.S. Senate Judiciary Committee, ahead of a planned hearing late this month, said Mylan NV appears to have greatly overcharged...
      Bayer applies for Regorafenib authorization to treat liver cancer

      Bayer applies for Regorafenib authorization to treat liver cancer

      supriya kashyap kashyap8 Nov 2016 11:56 AM IST
      German drugmaker Bayer said it submitted an application to have its cancer drug Regorafenib approved for the second-line treatment of liver cancer...
      Roche says flexible pricing ready for cancer, not MS drugs

      Roche says flexible pricing ready for cancer, not MS drugs

      supriya kashyap kashyap8 Nov 2016 11:26 AM IST
      Zurich : The spotlight on finding a cancer cure has spurred improvements in systems to collect and analyze oncology data, but efforts to track...
      Goa pharmacies to join strike against online drug delivery

      Goa pharmacies to join strike against online drug delivery

      supriya kashyap kashyap6 Nov 2016 11:58 AM IST
      Panaji : Calling Internet-based medicine and drug delivery portals as potential hubs for purchase of scheduled drugs and habit-forming pharmaceutical...
      Novo Nordisk defends US diabetes drug pricing

      Novo Nordisk defends US diabetes drug pricing

      supriya kashyap kashyap6 Nov 2016 11:09 AM IST
      Copenhagen : Danish diabetes drug maker Novo Nordisk defended its pricing of diabetes drugs after facing allegations of pricing collusion by U.S....
      Drugmakers under fire for possible US price fixing

      Drugmakers under fire for possible US price fixing

      supriya kashyap kashyap6 Nov 2016 11:09 AM IST
      Two prominent U.S. lawmakers called on federal antitrust regulators to probe whether Sanofi SA, Eli Lilly and Co, Merck & Co Inc and Novo Nordisk...
      Prev

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok